Trial Profile
Efficacy and safety of corifollitropin-alfa for controlled ovarian hyperstimulation: A case control study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Ganirelix; Recombinant follicle-stimulating hormone
- Indications Female infertility
- Focus Adverse reactions; Therapeutic Use
- 02 Feb 2016 New trial record